No Data
No Data
INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt
Inmune Bio Announces Stock Options and Leadership Changes
OmniScience and INmune Bio Collaborate to Enhance Clinical Trial Decision-Making With Vivo GenAI Platform
Express News | Omniscience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer’s Trial With Vivo, a Novel Genai Clinical Trial Control Tower
OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer's Trial With Vivo, a Novel GenAI Clinical Trial Control Tower
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease
No Data